Your browser doesn't support javascript.
loading
Phase 1/2 study of epacadostat in combination with durvalumab in patients with metastatic solid tumors.
Naing, Aung; Algazi, Alain P; Falchook, Gerald S; Creelan, Benjamin C; Powderly, John; Rosen, Seth; Barve, Minal; Mettu, Niharika B; Triozzi, Pierre L; Hamm, John; Zhou, Gongfu; Walker, Chris; Dong, Zhiwan; Patel, Manish R.
Affiliation
  • Naing A; MD Anderson Cancer Center, University of Texas, Houston, Texas, USA.
  • Algazi AP; University of California San Francisco, San Francisco, California, USA.
  • Falchook GS; Sarah Cannon Research Institute at HealthONE, Denver, Colorado, USA.
  • Creelan BC; Moffit Cancer Center, Tampa, Florida, USA.
  • Powderly J; Carolina BioOncology Institute, Huntersville, North Carolina, USA.
  • Rosen S; Hematology Oncology Associates of the Treasure Coast, Port St Lucie, Florida, USA.
  • Barve M; Mary Crowley Cancer Research, Dallas, Texas, USA.
  • Mettu NB; Duke University Medical Center, Durham, North Carolina, USA.
  • Triozzi PL; Wake Forest University, Winston-Salem, North Carolina, USA.
  • Hamm J; Norton Cancer Institute, Louisville, Kentucky, USA.
  • Zhou G; Incyte Corporation, Wilmington, Delaware, USA.
  • Walker C; Incyte Corporation, Wilmington, Delaware, USA.
  • Dong Z; Incyte Corporation, Wilmington, Delaware, USA.
  • Patel MR; Florida Cancer Specialists/Sarah Cannon Research Institute, Sarasota, Florida, USA.
Cancer ; 129(1): 71-81, 2023 01 01.
Article in En | MEDLINE | ID: mdl-36309837

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Neoplasms, Second Primary / Neoplasms Limits: Adult / Humans Language: En Journal: Cancer Year: 2023 Document type: Article

Full text: 1 Collection: 01-internacional Health context: 3_ND Database: MEDLINE Main subject: Neoplasms, Second Primary / Neoplasms Limits: Adult / Humans Language: En Journal: Cancer Year: 2023 Document type: Article